SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Munsch Frederick

(Last) (First) (Middle)
400 SOMERSET CORPORATE BLVD.

(Street)
BRIDGEWATER NJ 08807

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
06/01/2021
3. Issuer Name and Ticker or Trading Symbol
Bausch Health Companies Inc. [ BHC ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Controller and CAO
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares, No Par Value 21,172(1)(2) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Options (right to purchase) (3) 03/01/2027 Common Shares, No Par Value 8,046 14.38 D
Non-Qualified Stock Options (right to purchase) (3) 03/07/2028 Common Shares, No Par Value 12,172 15.32 D
Non-Qualified Stock Options (right to purchase) (3) 02/27/2029 Common Shares, No Par Value 8,506 23.16 D
Non-Qualified Stock Options (right to purchase) (3) 02/26/2030 Common Shares, No Par Value 11,265 24.77 D
Non-Qualified Stock Options (right to purchase) (3) 03/03/2031 Common Shares, No Par Value 6,683 32.56 D
Explanation of Responses:
1. Includes 14,616 Restricted Share Units ("RSUs") which will vest, subject to the reporting person's continued service, as follows: (i) 891 RSUs on February 26, 2022; (ii) 974 RSUs on February 27, 2022; (iii) 892 RSUs on February 26, 2023; (iv) 5,322 RSUs granted on March 3, 2021 that will vest in equal installments on each of the first three anniversaries of the date of grant; and (v) 6,537 RSUs granted on May 3, 2021 that will vest in equal in equal installments on each of the first three anniversaries of the date of grant.
2. Vested RSUs are settled in Common Shares, no par value, of the Issuer.
3. Vests in equal installments on each of the first three anniversaries of the date of grant.
/s/ Kirsten O'Donnell, attorney-in-fact for Frederick Munsch 06/03/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.